Applied Genetic Technologies

$3.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.24%) Today
-$0.04 (-1.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AGTC and other stocks, options, and ETFs commission-free!

About AGTC

Applied Genetic Technologies Corporation Common Stock, also called Applied Genetic Technologies, is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology.

CEO
Susan B. Washer
Employees
83
Headquarters
Alachua, Florida
Founded
1999
Market Cap
168.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.59M
High Today
$4.00
Low Today
$3.66
Open Price
$3.90
Volume
2.51M
52 Week High
$9.67
52 Week Low
$3.56

AGTC Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

DDT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure